chlorpromazine has been researched along with Movement Disorders in 130 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been reported that intraventricular injection of chlorpromazine methiodide (CPZMI), a quaternary ammonium derivative of chlorpromazine, in rats induces abnormal, twisting postures which may serve as an experimental model of the human movement disorder dystonia." | 3.66 | Electroencephalographic studies of chlorpromazine methiodide and somatostatin-induced barrel rotation in rats. ( Burke, RE; Fahn, S, 1983) |
| " Improvement was recorded in a double blind study of 18 patients treated with maximum tolerated dosage (mean 18." | 2.64 | Tardive dyskinesia treated with pimozide. ( Calne, DB; Claveria, LE; Haskayne, L; Lodge-Patch, IC; Pallis, CA; Petrie, A; Teychenne, PF, 1975) |
| "Acute dystonia can also be reliably induced in many primate species by neuroleptic treatment with comparable time course, symptomatology and pharmacological characteristics to those observed in man." | 2.37 | Acute dystonia induced by neuroleptic drugs. ( Jenner, P; Marsden, CD; Rupniak, NM, 1986) |
| " The ip LD50 of CPA was found to be 13 +/- 0." | 1.27 | Toxicity and neuropharmacology of cyclopiazonic acid. ( Cole, RJ; Dorner, JW; Nishie, K, 1985) |
| "Rats with ablated frontal sensorimotor cortex and one with ablated sensorimotor connections to forebrain showed more vacuous chewing movements following 6-week chronic administration of a neuroleptic than did occipitally damaged rats or normal controls who were treated in the same way." | 1.26 | Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. ( Glassman, HN; Glassman, RB, 1980) |
| "Reserpine pretreatment potentiates turning produced by (-)-ephedrine." | 1.25 | Turning behaviour as an index of the action of amphetamines and ephedrines on central dopamine-containing neurones. ( Christie, JE; Crow, TJ, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 123 (94.62) | 18.7374 |
| 1990's | 4 (3.08) | 18.2507 |
| 2000's | 2 (1.54) | 29.6817 |
| 2010's | 1 (0.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yehl, JL | 1 |
| Sheyner, I | 1 |
| Fasnacht, KS | 1 |
| Stewart, JT | 1 |
| Harris, DS | 1 |
| Wolkowitz, OM | 1 |
| Reus, VI | 1 |
| TATLOW, WF | 1 |
| FISHER, CM | 1 |
| DOBKIN, AB | 1 |
| GIACOBINI, E | 1 |
| OSTERMAN, E | 1 |
| BADER, E | 1 |
| FREED, H | 1 |
| PEIFER, CA | 1 |
| FLUGEL, F | 2 |
| BOURGUIGNON, A | 2 |
| DELAY, J | 2 |
| DENIKER, P | 2 |
| LEMPERIERE, T | 2 |
| Letailleur, M | 2 |
| Monnerie, R | 2 |
| Morin, J | 2 |
| SEDIARI, F | 1 |
| MORETTI, E | 1 |
| BLANC, M | 1 |
| LOISEAU, P | 1 |
| DES TERMES, M | 1 |
| STAEFFEN, J | 1 |
| SCHONECKER, M | 1 |
| ARRIGONI-MARTELLI, E | 1 |
| BISIANI, M | 1 |
| GENOVESE, E | 1 |
| HAASE, HJ | 1 |
| ABRAMCZUK, J | 1 |
| CHATAGNON, P | 1 |
| CHATAGNON, C | 1 |
| WILKIN, MO | 1 |
| FOURNIER, M | 1 |
| LORCY, P | 1 |
| SKORPIL, V | 1 |
| VYKLICKY, L | 1 |
| SIGWALD, J | 1 |
| BOUTTIER, D | 1 |
| RAYMONDEAUD, C | 1 |
| HANAU, R | 1 |
| KORANYI, L | 1 |
| ENDROECZI, E | 1 |
| LISSAK, K | 1 |
| LINDENBAUM, AL | 1 |
| HAEFNER, H | 1 |
| KUTSCHER, I | 1 |
| ECKMANN, F | 1 |
| IMMICH, H | 1 |
| ROOS, BE | 1 |
| STEG, G | 2 |
| ZSCHUCKE, CF | 1 |
| BOCKNER, S | 1 |
| STERN, J | 1 |
| WARD, AA | 1 |
| RODOVA, A | 1 |
| NAHUNEK, K | 1 |
| HUNTER, R | 1 |
| EARL, CJ | 1 |
| THRONICROFT, S | 1 |
| Faurbye, A | 2 |
| Clausen, J | 1 |
| Rasch, PJ | 1 |
| Petersen, PB | 1 |
| Brandborg, G | 1 |
| Pakkenberg, H | 1 |
| KILPATRICK, R | 1 |
| WHYTE, JH | 1 |
| ORWIN, A | 1 |
| SIM, M | 1 |
| BOZZI, R | 1 |
| BRUNO, A | 1 |
| ALLEGRANZA, A | 1 |
| BISHOP, MP | 1 |
| GALLANT, DM | 2 |
| MANGHI, E | 1 |
| READ, D | 1 |
| FURST, A | 1 |
| CUTTING, W | 1 |
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Burakova, NS | 1 |
| Glassman, RB | 1 |
| Glassman, HN | 1 |
| Burke, RE | 1 |
| Fahn, S | 1 |
| Folstein, S | 1 |
| Folstein, M | 1 |
| Gingell, K | 1 |
| Nadarajah, J | 1 |
| Hanaoka, Y | 1 |
| Ohi, T | 1 |
| Matsukura, S | 1 |
| Puri, BK | 1 |
| Barnes, TR | 1 |
| Chapman, MJ | 1 |
| Hutton, SB | 1 |
| Joyce, EM | 1 |
| Gardos, G | 1 |
| Cole, JO | 1 |
| Vatsek, Ia | 1 |
| Claveria, LE | 1 |
| Teychenne, PF | 1 |
| Calne, DB | 1 |
| Haskayne, L | 1 |
| Petrie, A | 1 |
| Pallis, CA | 1 |
| Lodge-Patch, IC | 1 |
| Van Praag, HM | 2 |
| Korf, J | 1 |
| Hogarty, GE | 1 |
| Ulrich, RF | 1 |
| Mussare, F | 1 |
| Aristigueta, N | 1 |
| Klawans, HL | 6 |
| Moses, H | 1 |
| Nausieda, PA | 1 |
| Bergen, D | 2 |
| Weiner, WJ | 2 |
| Kamen, S | 1 |
| Silva, MT | 1 |
| Calil, HM | 1 |
| Sassin, JF | 1 |
| Paulson, GW | 3 |
| Rizvi, CA | 1 |
| Crane, GE | 8 |
| Curran, DJ | 1 |
| Nagaswami, S | 1 |
| Mohan, KJ | 1 |
| Dankova, J | 1 |
| Boucher, R | 1 |
| Poirier, LJ | 2 |
| Casey, DE | 2 |
| Denny, D | 1 |
| Messiha, FS | 3 |
| Sayers, AC | 1 |
| Bürki, HR | 1 |
| Ruch, W | 1 |
| Asper, H | 1 |
| Ogita, K | 1 |
| Yagi, G | 1 |
| Itoh, H | 1 |
| Laing, RW | 1 |
| Howell, SJ | 1 |
| Rupniak, NM | 1 |
| Jenner, P | 2 |
| Marsden, CD | 3 |
| Nishie, K | 1 |
| Cole, RJ | 1 |
| Dorner, JW | 1 |
| Kihara, H | 1 |
| Valente, M | 1 |
| Porter, MT | 1 |
| Fluharty, AL | 1 |
| Kamianov, IM | 1 |
| Kupisk, AG | 1 |
| Katsen, IZ | 1 |
| Forrest, FM | 1 |
| Niturad, A | 1 |
| Ciurezu, T | 1 |
| Cucu, I | 1 |
| Elie, R | 1 |
| Gagnon, MA | 1 |
| Lamontagne, Y | 1 |
| Tetreault, L | 2 |
| Gamburg, AL | 1 |
| Komel'kevtsch, IuN | 1 |
| Aronov, EL | 1 |
| Dill, RE | 1 |
| Lance, JW | 1 |
| Andrews, C | 1 |
| Turunen, S | 1 |
| Achté, KA | 1 |
| Semanovskaia, EI | 1 |
| Hertrich, O | 1 |
| Bordeleau, JM | 1 |
| Bullock, RJ | 1 |
| McKenzie, GM | 1 |
| Gordon, RJ | 1 |
| Viik, K | 1 |
| Hussey, HH | 1 |
| Miller, EM | 1 |
| Denney, D | 1 |
| Watts, RW | 1 |
| McKeran, RO | 1 |
| Brown, E | 1 |
| Andrews, TM | 1 |
| Griffiths, MI | 1 |
| Dols, LC | 1 |
| Rubovits, R | 2 |
| Briones, AV | 1 |
| Thornton, WE | 1 |
| Thornton, BP | 1 |
| Smeets, RA | 1 |
| Bruyn, GW | 1 |
| Duvoisin, RC | 2 |
| Dolphin, A | 1 |
| Tarsy, D | 1 |
| Teusink, JP | 1 |
| Bishop, M | 1 |
| Guerrero-Figueroa, R | 1 |
| Greenblatt, DL | 1 |
| Dominick, JR | 1 |
| Stotsky, BA | 1 |
| DiMascio, A | 1 |
| Millichap, JG | 1 |
| Fowler, GW | 1 |
| Naranjo, ER | 1 |
| Bucci, L | 1 |
| Godwin-Austen, RB | 1 |
| Clark, T | 1 |
| Villeneuve, A | 1 |
| Carruthers, SG | 1 |
| McKendall, RR | 1 |
| Christie, JE | 1 |
| Crow, TJ | 1 |
| Goldstein, S | 1 |
| Himwich, WA | 1 |
| Leiner, K | 1 |
| Stout, M | 1 |
| Demars, JP | 1 |
| Radzuweit, H | 1 |
| Knorr, W | 1 |
| Bilyk, VD | 1 |
| Gurovich, IIa | 1 |
| Fleĭs, EP | 1 |
| Yaryura-Tobias, JA | 1 |
| Wolpert, A | 1 |
| Dana, L | 1 |
| Merlis, S | 1 |
| Chase, TN | 1 |
| Schnur, JA | 1 |
| Gordon, EK | 1 |
| Malm, U | 1 |
| Fréjaville, JP | 1 |
| Guyochin, A | 1 |
| Gaultier, M | 1 |
| Galambos, E | 1 |
| Pfeifer, AK | 1 |
| György, L | 1 |
| Molnár, J | 1 |
| Angle, CR | 1 |
| McIntire, MS | 1 |
| Kennedy, PF | 1 |
| Blazsó, S | 1 |
| Roy, P | 1 |
| St-Jean, A | 1 |
| Ban, T | 1 |
| Noe, W | 1 |
| Meyer, HH | 1 |
| Eisenberg, L | 1 |
10 reviews available for chlorpromazine and Movement Disorders
| Article | Year |
|---|---|
[COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
Topics: Agranulocytosis; Autonomic Nervous System Diseases; Chemical and Drug Induced Liver Injury; Chlorpro | 1964 |
NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
Topics: Anticonvulsants; Chlorpromazine; Dopamine; Extrapyramidal Tracts; Humans; Monoamine Oxidase Inhibito | 1964 |
[Ballism, hemiballism].
Topics: Cerebrovascular Disorders; Chlorpromazine; Electromyography; Haloperidol; Humans; Movement Disorders | 1993 |
Maintenance antipsychotic therapy: is the cure worse than the disease?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Clinical Trials as To | 1976 |
[Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Humans; Hyperkinesis; Movement Disorde | 1976 |
Drug-induced dyskinesia in monkeys.
Topics: Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Azides; Carbachol; Caudate Nucle | 1975 |
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease M | 1986 |
Nervous mechanisms involved in experimentally induced extrapyramidal disturbances.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Brain; Cats; Caudate Nucleus; Cerebellar Nuclei; Chlor | 1974 |
Pathological aspects on Parkinson's syndrome.
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Central Nervous System; Chlorpromazine; Corpus Stria | 1972 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinic | 1967 |
13 trials available for chlorpromazine and Movement Disorders
| Article | Year |
|---|---|
Maintenance antipsychotic therapy: is the cure worse than the disease?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Clinical Trials as To | 1976 |
Tardive dyskinesia treated with pimozide.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Consciousnes | 1975 |
Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
Topics: Adolescent; Child; Chlorpromazine; Clinical Trials as Topic; Diagnosis, Differential; Dystonia Muscu | 1975 |
Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
Topics: Acute Disease; Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Esters; Female; Fluphenazine; | 1973 |
Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
Topics: Acute Disease; Antidepressive Agents; Chlorpromazine; Clinical Trials as Topic; Haloperidol; Humans; | 1967 |
Phenothiazine-induced dyskinesia in nursing-home patients.
Topics: Aged; Brain Damage, Chronic; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Mental | 1968 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinic | 1967 |
High doses of trifluperazine and tardive dyskinesia.
Topics: Adult; Age Factors; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Humans; Movement Diso | 1970 |
Motor disorders induced by neuroleptics: a proposed new classification.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dystonia Musculorum Deformans; Factor A | 1971 |
The dyskenesias: a new therapeutic approach.
Topics: Chlorpromazine; Clinical Trials as Topic; Female; Humans; Isocarboxazid; Male; Middle Aged; Monoamin | 1971 |
Persistent phenothiazine dyskinesia treated with tetrabenazine.
Topics: Aged; Chlorpromazine; Clinical Trials as Topic; Diazepam; Facial Expression; Humans; Male; Movement | 1971 |
Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy.
Topics: Aged; Chlorpromazine; Clinical Trials as Topic; Electric Stimulation Therapy; Female; Haloperidol; H | 1966 |
Persistence of neurological symptoms due to neuroleptic drugs.
Topics: Adult; Chlorpromazine; Female; Humans; Male; Middle Aged; Movement Disorders; Placebos; Time Factors | 1971 |
109 other studies available for chlorpromazine and Movement Disorders
| Article | Year |
|---|---|
A case of tardive dyskinesia in the last weeks of life.
Topics: Anti-Dyskinesia Agents; Chlorpromazine; Haloperidol; Hiccup; Hospice Care; Humans; Male; Middle Aged | 2015 |
Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dehydroepiandrosterone; Female; Humans; Hydrocort | 2001 |
The clinical effects of chlorpromazine on dyskinesia.
Topics: Chlorpromazine; Dyskinesias; Humans; Movement Disorders; Physical Therapy Modalities | 1954 |
[Neurological disorders due to hibernal therapy].
Topics: Chlorpromazine; Movement; Movement Disorders; Nervous System Diseases | 1954 |
Extrapyramidal symptoms following thorazine medication.
Topics: Basal Ganglia Diseases; Chlorpromazine; Humans; Movement; Movement Disorders | 1956 |
Treatment of hyperkinetic emotionally disturbed children with prolonged administration of chlorpromazine.
Topics: Child; Chlorpromazine; Emotions; Humans; Movement Disorders | 1956 |
[Systematic neuroleptic therapy with the appearance of parkinsonian states].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement Disorders; Reserpine | 1956 |
[Systematic neuroleptic therapy with the appearance of parkinsonian states].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement Disorders; Reserpine | 1956 |
[Systematic neuroleptic therapy with the appearance of parkinsonian states].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement Disorders; Reserpine | 1956 |
[Systematic neuroleptic therapy with the appearance of parkinsonian states].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement Disorders; Reserpine | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Pseudo-Parkinsonian Transient Syndromes Caused by Chlorpromazine].
Topics: Chlorpromazine; Humans; Movement Disorders | 1956 |
[Pseudo-Parkinsonian Transient Syndromes Caused by Chlorpromazine].
Topics: Chlorpromazine; Humans; Movement Disorders | 1956 |
[Pseudo-Parkinsonian Transient Syndromes Caused by Chlorpromazine].
Topics: Chlorpromazine; Humans; Movement Disorders | 1956 |
[Pseudo-Parkinsonian Transient Syndromes Caused by Chlorpromazine].
Topics: Chlorpromazine; Humans; Movement Disorders | 1956 |
[Chlorpromazine in dyskinesias].
Topics: Chlorpromazine; Dyskinesias; Humans; Movement Disorders; Physical Therapy Modalities | 1956 |
[Myoclonias during chlorpromazine treatment; analysis].
Topics: Chlorpromazine; Humans; Movement Disorders; Muscular Diseases; Myoclonus | 1957 |
[Paroxysmal dyskinesia as the effect of megaphen].
Topics: Chlorpromazine; Chorea; Movement; Movement Disorders | 1957 |
[Effect of phenothiazine derivatives on increased motility of the mouse].
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Chlorpromazine; Methylphenidate; Mice; Mov | 1958 |
[Therapeutic value of extra-pyramidal symptoms in chlorpromazine & reserpine therapy].
Topics: Chlorpromazine; Extrapyramidal Tracts; Handwriting; Humans; Movement Disorders; Reserpine | 1958 |
[On the appearance of acathisia during neuroleptic therapy].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement; Movement Disorders; Psychiatric Somatic Ther | 1960 |
[Dyskinetic facio-bucco-lingual and choreic syndrome with hemiballism of chlorpromazine origin].
Topics: Chlorpromazine; Dyskinesias; Humans; Movement; Movement Disorders; Tongue | 1961 |
[Effect of largactil on the EMG in lesions of the motor system].
Topics: Chlorpromazine; Electromyography; Humans; Movement Disorders | 1960 |
[Chlorproethazine. Its importance in neurology].
Topics: Chlorpromazine; Disease; Movement Disorders; Neurology; Pyramidal Tracts; Tranquilizing Agents | 1961 |
[Clinical contribution to the knowledge of the extrapyramidal syndrome caused by neuroplegics].
Topics: Basal Ganglia Diseases; Brain Diseases; Chlorpromazine; Extrapyramidal Tracts; Humans; Knowledge; Mo | 1963 |
HYPERMOTILITY EVOKED BY LESIONS OF THE SEPTUM AND ANTERIOR HYPOTHALAMUS.
Topics: Aminopyrine; Amygdala; Atropine; Body Temperature; Caudate Nucleus; Cerebral Ventricles; Chlorpromaz | 1963 |
[ON THE EFFECT OF AMINAZIN AND PARSIDOL ON THE COORDINATION OF MOVEMENTS IN CEREBRAL PALSY IN CHILDREN].
Topics: Cerebral Palsy; Child; Chlorpromazine; Humans; Infant; Movement; Movement Disorders; Muscle Relaxant | 1963 |
[NEUROLEPTICS AND DYSKINETIC REACTIONS].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Chlorprothixene; Depression; Fluphenazine; M | 1963 |
THE EFFECT OF L-3, 4-DIHYDROXYPHENYLALANINE AND DL-5-HYDROXYTRYPTOPHAN ON RIGIDITY AND TREMOR INDUCED BY RESERPINE, CHLORPROMAZINE AND PHENOXYBENZAMINE.
Topics: 5-Hydroxytryptophan; Amino Acids; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Inulin; Movement | 1964 |
[ON THE ANTAGONISM OF THE ACTION OF NEUROLEPTICS AND ANTIPARKINSON AGENTS].
Topics: Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Handwriting; Humans; Movement Disorders; | 1964 |
NEUROLOGICAL SYMPTOMS WITH PHENOTHIAZINES.
Topics: Brain Diseases; Chlorpromazine; Movement Disorders; Neurologic Manifestations; Parkinsonian Disorder | 1964 |
THE RELATIONSHIP OF THE ALPHA AND GAMMA MOTOR SYSTEMS TO THE EFFICACY OF THE SURGICAL THERAPY OF PARKINSONISM.
Topics: Brain; Chlorpromazine; Globus Pallidus; Humans; Movement Disorders; Neurosurgery; Parkinsonian Disor | 1963 |
[PERSISTENT DYSKINESIA AFTER PHENOTHIAZINES].
Topics: Antipsychotic Agents; Brain Concussion; Chlorpromazine; Dyskinesias; Geriatrics; Hypertension; Intra | 1964 |
AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.
Topics: Brain; Brain Damage, Chronic; Brain Diseases; Chlorpromazine; Chorea; Diagnosis, Differential; Elect | 1964 |
CHANGES IN SERUM PROTEINS AND CEREBROSPINAL FLUID PROTEINS DURING PHARMACOTHERAPY OF PSYCHOSES.
Topics: Alcoholism; Bipolar Disorder; Blood Proteins; Cerebrospinal Fluid Proteins; Chlorpromazine; Drug The | 1964 |
SIDE-EFFECTS OF PHENOTHIAZINE DRUGS.
Topics: Bipolar Disorder; Chlorpromazine; Movement Disorders; Phenothiazines; Psychotic Disorders; Toxicolog | 1965 |
PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES.
Topics: Antipsychotic Agents; Chlorpromazine; Movement Disorders; Phenothiazines | 1965 |
URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
Topics: Autonomic Nervous System Diseases; Chlorpromazine; Drug Therapy; Extrapyramidal Tracts; Fluids and S | 1965 |
SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
Topics: Antidepressive Agents; Biomedical Research; Chlorpromazine; Chlorprothixene; Drug Therapy; Extrapyra | 1965 |
[Largactil (R.P.4560) in hypertonic and dyskinetic syndromes].
Topics: Chlorpromazine; Chorea; Dyskinesias; Humans; Movement Disorders; Parkinson Disease; Syndrome | 1954 |
Effect of chlorpromazine and thiouracil on the circling syndrome produced in mice by dimethylaminohexose reductone.
Topics: Animals; Chlorpromazine; Malondialdehyde; Mice; Movement Disorders; Thiouracil | 1960 |
U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Chlorpromazine; Disease Models, Animal; Dyskinesia, Dru | 2007 |
[A case of hyperkinesia caused by unilateral lesion of the medial part of the thalamus in a dog].
Topics: Animals; Brain Injuries; Chlorpromazine; Dogs; Head; Humans; Hyperkinesis; Movement Disorders; Paras | 1966 |
Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Chlorpromazine; Di | 1980 |
Electroencephalographic studies of chlorpromazine methiodide and somatostatin-induced barrel rotation in rats.
Topics: Animals; Behavior, Animal; Chlorpromazine; Disease Models, Animal; Dystonia; Electroencephalography; | 1983 |
Diagnosis and treatment of Huntington's disease.
Topics: Affective Symptoms; Amitriptyline; Chlorpromazine; Cognition Disorders; Counseling; Deglutition Diso | 1981 |
A controlled community study of movement disorder in people with learning difficulties on anti-psychotic medication.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Diagnosis, Differential; Dose-Response Relationship, Dr | 1994 |
Spontaneous dyskinesia in first episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Middle Aged; Movement | 1999 |
Neuroleptics, catecholamines, and psychoses: a study of their interrelations.
Topics: Adolescent; Adult; Brain; Brain Chemistry; Catecholamines; Chlorpromazine; Depression, Chemical; Dop | 1975 |
Drug discontinuation among long term, successfully maintained schizophrenic outpatients.
Topics: Ambulatory Care; Chlorpromazine; Humans; Movement Disorders; Recurrence; Schizophrenia; Schizophreni | 1976 |
Treatment and prognosis of hemiballismus.
Topics: Acute Disease; Aged; Chlorpromazine; Diencephalon; Dopamine; Feedback; Female; Haloperidol; Homovani | 1976 |
Tardive dyskinesia. A significant syndrome for geriatric dentistry.
Topics: Aged; Arteriosclerosis; Bruxism; Chlorpromazine; Dementia; Denture, Complete; Depression; Depressive | 1975 |
Screening hallucinogenic drugs: systematic study of three behavioral tests.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Apomorphine; Arousal; Behavior, Animal; Chlorpromazine; D | 1975 |
Tardive dyskinesia.
Topics: Chlorpromazine; Diagnosis, Differential; Female; History, 20th Century; Humans; Male; Movement Disor | 1975 |
Treatment of phenothiazine induced bulbar persistent dyskinesia with deanol acetamidobenzoate.
Topics: Acetamides; Adult; Benzoates; Chlorpromazine; Deanol; Ethanolamines; Humans; Male; Movement Disorder | 1975 |
Role of the strio-pallidal system and motor cortex in induced circus movements in rats and cats.
Topics: Animals; Apomorphine; Brain Mapping; Cats; Chlorpromazine; Corpus Striatum; Dextroamphetamine; Drug | 1975 |
Deanol in the treatment of tardive dyskinesia.
Topics: Chlorpromazine; Deanol; Ethanolamines; Humans; Male; Middle Aged; Movement Disorders; Trifluoperazin | 1975 |
Drug-induced dyskinesia and urinary catecholamines.
Topics: Animals; Catecholamines; Chlorpromazine; Macaca mulatta; Movement Disorders | 1975 |
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzazepines; Dibenzoxazepines; | 1975 |
Comparative analysis of persistent dyskinesias of long-term usage with neuroleptics in France and in Japan.
Topics: Adult; Chlorpromazine; Female; Fluphenazine; France; Humans; Japan; Male; Middle Aged; Movement Diso | 1975 |
Acute bilateral ballism in a patient with intravascular dissemination of gastric carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bronchopneumonia; Chlorpromazine; Female; Humans; Movement | 1992 |
Toxicity and neuropharmacology of cyclopiazonic acid.
Topics: Animals; Body Weight; Chlorpromazine; Electrocardiography; Electroencephalography; Heart Rate; Hexob | 1985 |
Hyperdibasicaminoaciduria in a mentally retarded homozygote with a peculiar response to phenothiazines.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Antipsychotic Agents; Arginine; Chlorpromazine; Cy | 1973 |
Drug-induced extrapyramidal symptoms. A cooperative study.
Topics: Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Butyrophenones; Chlorpromazine; | 1973 |
[Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Catatonia; Chlorpromazine; Facial Mus | 1973 |
Evolutionary origin of extrapyramidal disorders in drug-treated mental patients, its significance, and the role of neuromelanin.
Topics: Amphibians; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Biological Evolution; Chlorpromaz | 1974 |
Maintenance treatment of schizophrenia with long-acting fluphenazine.
Topics: Adult; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Movem | 1974 |
The extrapyramidal neuroleptic syndrome: description and measurement.
Topics: Basal Ganglia Diseases; Chlorpromazine; Electromyography; Facial Muscles; Gait; Humans; Movement Dis | 1973 |
A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.
Topics: 5-Methoxytryptamine; Animals; Biogenic Amines; Chlorpromazine; Dopamine; Epinephrine; Female; Haplor | 1974 |
Lingual-facial-buccal movements in the elderly. I. Pathophysiology and treatment.
Topics: Aged; Amphetamine; Chemoreceptor Cells; Chlorpromazine; Corpus Striatum; Dopamine Antagonists; Facia | 1973 |
[Neurohumoral regulation of the lability of myoneural synapses in schizophrenic patients].
Topics: Acetylcholine; Adrenocorticotropic Hormone; Adult; Atropine; Catatonia; Chlorpromazine; Chronaxy; Co | 1969 |
Mescaline: receptor interaction in the rat striatum.
Topics: Animals; Basal Ganglia; Behavior, Animal; Caudate Nucleus; Chlorpromazine; Cyclic AMP; Dopamine; Dru | 1972 |
Dysaesthesia-dyskinesia: a syndrome of painful legs and moving toes.
Topics: Aged; Amantadine; Amitriptyline; Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Leg; Moveme | 1973 |
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
Topics: Adult; Aged; Brain Damage, Chronic; Cheek; Chlorpromazine; Chlorprothixene; Clopenthixol; Female; Ha | 1967 |
[Affective disorders in the course of treatment with neuroleptics of children and adolescents with schizophrenia].
Topics: Adolescent; Affect; Child; Child, Preschool; Chlorpromazine; Depression; Haloperidol; Humans; Moveme | 1967 |
[Neuroleptics, thymoleptics and tranquilizers in neurological therapy].
Topics: Basal Ganglia Diseases; Chlordiazepoxide; Chlorpromazine; Diazepam; Epilepsy; Extrapyramidal Tracts; | 1969 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperid | 1972 |
Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia.
Topics: Aged; Antipsychotic Agents; Athetosis; Basal Ganglia Diseases; Chlorpromazine; Chorea; Female; Human | 1972 |
Some biochemical and behavioural correlates of a possible animal model of human hyperkinetic syndromes.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Catecholamines; Cats; Caudate Nucleus; Chlorpromaz | 1972 |
Editorial: Tardive dyskinesias.
Topics: Adult; Age Factors; Aged; Anxiety Disorders; Chlorpromazine; Chronic Disease; Female; Gastritis; Hum | 1974 |
Letter: Deanol: a solution for tardive dyskinesia?
Topics: Aged; Chlorpromazine; Deanol; Ethanolamines; Female; Humans; Male; Middle Aged; Movement Disorders; | 1974 |
Letter: Dimethylaminoethanol in tardive dyskinesia.
Topics: Chlorpromazine; Deanol; Ethanolamines; Humans; Male; Middle Aged; Movement Disorders; Trifluoperazin | 1974 |
The relationship of dopamine excretion to chlorpromazine-induced dyskinesia in monkeys.
Topics: Administration, Intranasal; Animals; Chlorpromazine; Dopamine; Homovanillic Acid; Intubation; Macaca | 1974 |
Clinical and biochemical studies on treatment of Lesch-Nyhan syndrome.
Topics: Adenine; Allopurinol; Body Weight; Child, Preschool; Chlorpromazine; Creatinine; Exchange Transfusio | 1974 |
An experimental model of tardive dyskinesia.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disease Models | 1972 |
The dyskinetic syndrome.
Topics: Chlorpromazine; Female; Humans; Middle Aged; Movement Disorders; Schizophrenia, Paranoid | 1973 |
Rapid reversal of tardive dyskinesia.
Topics: Adult; Chlorpromazine; Dibenzoxepins; Female; Haloperidol; Humans; Movement Disorders; Neurologic Ma | 1973 |
Letter: Tardive dyskinesia and low dosage.
Topics: Chlorpromazine; Fluphenazine; Humans; Hypnotics and Sedatives; Movement Disorders; Promethazine; Psy | 1973 |
Tardive dyskinesia and drug therapy in geriatric patients.
Topics: Aged; Chlorpromazine; Diagnosis, Differential; Female; Hospitalization; Hospitals, Psychiatric; Huma | 1974 |
Neuroleptic-induced tardiave dyskinesias in nonpsychotic patients.
Topics: Adult; Aged; Anxiety Disorders; Chlorpromazine; Female; Gastritis; Humans; Male; Middle Aged; Moveme | 1974 |
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose | 1974 |
Factors predisposing to drug-induced neurologic effects.
Topics: Age Factors; Antiparkinson Agents; Central Nervous System Diseases; Chlorpromazine; Chronic Disease; | 1974 |
Role of noradrenaline in levodopa reversal of reserpine akinesia.
Topics: Animals; Chlorpromazine; Dihydroxyphenylalanine; Haloperidol; Mice; Movement Disorders; Norepinephri | 1974 |
Tardive dyskinesia.
Topics: Adult; Anxiety; Chlorpromazine; Humans; Meprobamate; Movement Disorders; Neurologic Examination; Phe | 1974 |
The rabbit syndrome. A peculiar extrapyramidal reaction.
Topics: Aged; Anxiety; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Fatigue; Female; Humans; Male; M | 1972 |
Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
Topics: Amphetamine; Animals; Basal Ganglia; Basal Ganglia Diseases; Brain Chemistry; Caudate Nucleus; Chlor | 1972 |
Persistent tardive dyskinesia.
Topics: Aged; Chlorpromazine; Female; Humans; Movement Disorders; Phenothiazines; Prognosis | 1971 |
Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia.
Topics: Aged; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Facial Muscles; Female; Haloperidol; Humans; | 1971 |
Turning behaviour as an index of the action of amphetamines and ephedrines on central dopamine-containing neurones.
Topics: Amphetamine; Animals; Chlorpromazine; Corpus Striatum; Dextroamphetamine; Dopamine; Ephedrine; Explo | 1971 |
Psychoactive agents in dogs with bilateral lesions in subcortical structures.
Topics: 5-Hydroxytryptophan; Animals; Caudate Nucleus; Chlorpromazine; Dogs; Dopamine; Haloperidol; Hippocam | 1971 |
[Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
Topics: Adolescent; Adult; Aged; Butyrophenones; Chlorpromazine; Dementia; Depressive Disorder, Major; Dysau | 1969 |
[Etiology, clinical aspects and treatment of hemiballismus].
Topics: Chlorpromazine; Female; Humans; Male; Movement Disorders | 1969 |
[A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
Topics: Aged; Bipolar Disorder; Chlorpromazine; Chronic Disease; Extrapyramidal Tracts; Female; Haloperidol; | 1969 |
Action of L-Dopa in drug induced extrapyramidalism.
Topics: Adult; Chlorpromazine; Chronic Disease; Dihydroxyphenylalanine; Extrapyramidal Tracts; Female; Human | 1970 |
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
Topics: Amines; Brain; Chlorpromazine; Extrapyramidal Tracts; Female; Humans; Hydroxyindoleacetic Acid; Move | 1970 |
Intramuscular long-acting fluphenazine in the treatment of schizophrenia.
Topics: Administration, Oral; Adult; Aged; Chlorpromazine; Chronic Disease; Fluphenazine; Haloperidol; Human | 1970 |
[152 cases of acute poisoning by phenothiazine amines].
Topics: Absorption; Adolescent; Adult; Aged; Agranulocytosis; Anesthesia, General; Anesthesia, Obstetrical; | 1970 |
Study on the excitation induced by amphetamine, cocaine and alpha-methyltryptamine.
Topics: Amphetamine; Animals; Atropine; Benactyzine; Central Nervous System; Chlorpromazine; Cocaine; Mice; | 1967 |
Persistent dystonia in a brain-damaged child after ingestion of phenothiazine.
Topics: Brain Damage, Chronic; Child; Chlorpromazine; Female; Humans; Intellectual Disability; Movement Diso | 1968 |
Dyskinesia and neuroleptics.
Topics: Adult; Chlorpromazine; Chronic Disease; Fluphenazine; Hospitalization; Humans; Male; Middle Aged; Mo | 1968 |
Chorea and phenothiazines.
Topics: Aged; Chlorpromazine; Chorea; Female; Humans; Movement Disorders; Phenothiazines; Schizophrenia; Sub | 1969 |
[On the pharmacotherapeutic treatment of cerebral palsy. I. Treatment of movement disorders].
Topics: Cerebral Palsy; Child; Child, Preschool; Chlorpromazine; Humans; Infant; Infant, Newborn; Mephenesin | 1965 |
Studies with antiparkinsonian drugs with chronic psychiatric patients.
Topics: Adult; Aged; Chlorpromazine; Extrapyramidal Tracts; Humans; Mental Disorders; Middle Aged; Movement | 1966 |
[On the question of possible irreversible disorders due to psychopharmacotherapy].
Topics: Adult; Autonomic Nervous System; Biperiden; Butyrophenones; Central Nervous System; Chlorpromazine; | 1966 |
The management of the hyperkinetic child.
Topics: Child; Child, Preschool; Chlorpromazine; Dextroamphetamine; Diphenhydramine; Environment; Family; Hu | 1966 |